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Background: Long term oxygen therapy improves survival in hypoxemic patients with chronic obstructive
pulmonary disease (COPD). Because pressure support ventilation with a home care ventilator is largely
unsupervised, there is considerable risk of leakage occurring, which could affect delivered FiO2. We have therefore
conducted a bench study in order to measure the effect of different levels of O2 supply and degrees of leakage on
delivered FiO2. Ventilator tested: Legendair
W (Airox™, Pau, France). Thirty-six measures were performed in each four
ventilators with zero, 5 and 10 l.min-1 leakage and 1,2,4 and 8 l O2 flow.
Findings: FiO2 decreased significantly with 5 l.min-1 leakage for all O2 flow rates, and with 10 l.min-1 at 4 and 8 l.
min-1 O2.
Conclusion: During application of NIV on home ventilators, leakage can dramatically decrease inspired FiO2
making it less effective. It is important to know the FiO2 dispensed when NIV is used for COPD at home. We would
encourage industry to develop methods for FiO2 regulation Chronic use of NIV for COPD with controlled FiO2 or
SpO2 requires further studys.
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Long-term oxygen therapy (LTOT) improves survival in
hypoxemic patients with chronic obstructive pulmonary
disease (COPD) [1,2]. The minimum recommended
duration of O2 therapy is 15 hours per day. Non-invasive
ventilation (NIV) is now recommended for acute on
chronic COPD respiratory distress, whereas its chronic
use is more controversial [3,4]. Nocturnal non-invasive
ventilation (NIV) improves quality of life and blood gas
status, with fewer intensive care admissions, although
survival is not affected [5,6]. Most home care ventilators
deliver pressure support via a turbine and a constant
normobaric O2 supply [7,8]. The O2 source is liquid O2
or from extractors. We hypothesized that, whereas ICU
ventilators deliver the set Fi02 (hyperbaric 02 witch
permits variable O2 supply), with pressure support NIV,
leakage around the mask could influence the received
FiO2. Indeed leaks are well compensated by modern’s* Correspondence: goutorbephil@live.fr
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reproduction in any medium, provided the orhome ventilators by delivering higher flows, using an
additional volume taken from the room air. Under constant
O2 supply FiO2 should decrease. We therefore analysed
the variation of delivered FiO2 in pressure support
ventilation with a home care ventilator under different
levels of O2 supply and leakage in a bench study.
Material and method
Experimental bench study
A LegendairW (Airox™, Pau, France) ventilator was set to
give pressure support ventilation (PSV) with an expiratory
pressure (PE) of 5 cmH2O and inspiratoty pressure (PI) of
15 cmH2O. A standard single circuit with valve was
used to connect the ventilator with the test chamber. In
place of the mask we used a ‘leaks valve’, which could
allow 0, 5 or 10 l.min-1 leakage. The level of leakage was
calibrated during a continuous airway pressure 10
cmH2O, with two pneumotachographs one before and
one after the valve (Fleisch 6V, Lausanne, Switzerland).
Signals were digitized by an analogic/digital system
(MP150, Biopac Systems, Goleta, CA) with modules
(DA 100V 1000z, Biopac System). The O2 supply wasral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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FlowAnalyser PF-300 (Imtmedical, Switzerland).
The test lung was the two-chamber Michigan test lung
(Training/test lung-TTLW, adult infant lung simulator;
Michigan Instrument™, Grand Rapids, MI), which has
been described in detail in previous studies [9,10]; the
infant lung was used as driving chamber and linked with
the pressurized (test) chamber. The driving ventilator
Puritan Bennet (PB) 840 (set in controlled ventilation)
produces a negative pressure in the adult chamber,
which is recognized as an inspiratory effort by the test
ventilator. The characteristics of the test chamber were
that of a parabolic airway resistor of 20-cmH2O l-1.s-1
(PneufloW Airway resistor; Michigan Instrument™, Grand
Rapids, MI) and compliance was set at 60 ml/cmH2O.
The respiratory rate of the driving ventilator was set to 15
per minute. The oxygen fraction in the test chamber was
measured with a Puritan Bennet™ O2 Monitor 7820.
We tested four flows of oxygen supply (1, 2, 4 and 8
liters/minute) and FiO2 for each with a 0, 5 and 10 liter/
minute leak. The test chamber FiO2 was noted three times
for each condition (Figure 1).
The Kruskal-Walis test was used to compare all
variables and the post hoc Steel test if significance
was found. All data are presented as group median
[25–75]. Statistical analysis was performed with JMP
9.3 (SAS Institute, Cary, NC). Statistical significance was
defined as p < 0.05.Figure 1 Show the bench test.Findings
Four different ventilators were tested three times each, with
12 measurements of FiO2 for each condition of oxygen
supply and leakage. Leakage significantly affected FiO2 for
all O2 supply between no leak and 5 liters per minute of
leaks. FiO2 decreased significantly with 10 liters per
minute of leaks only for 4 and 8 liters O2 supply (Table 1
and Figure 2).
Discussion
The bench study confirms our hypothesis in six cases of
eight; FiO2 decreases with all O2 flows with 5 liters per
minute leaks and with 4 and 8 liters O2 supply with 10
liters per minute of leaks. We are not able to explain
why in several conditions FiO2 increased with 10 liters
per minute of leaks. We assume that it would be possible
venturi effect with increased O2 flow but this one
was continuously measured by a FlowAnalyser PF-300
(Imtmedical, Switzerland) and it was constant.
The Nocturnal Oxygen Therapy Trial (NOTT) and the
Medical Research Council study, using similar inclusion
criteria, demonstrated the beneficial effects of LTOT
on survival in subjects with COPD and severe resting
hypoxemia. The median survival in those using O2 for
15 hours/day was approximately twice that of those
receiving no O2 [1,2]. The use NIV in acute exacerbation
of COPD is now recommended. Two RCTs of long term
NIV for respiratory failure failed to demonstrate any effect
Table 1 Comparison of FiO2 according leakages and oxygen supply
Leakage (liters per minute)
0 5 10
n = 12 n = 12 n = 12
Oxygen supply
1 l/min 24.2 [23.7 - 24.4] 23.6 [23.2 - 23.9]* 25.1 [23.8 - 25.1]
2 l/min 28.6 [28.5 - 28.8] 27.0 [26.1 - 27.6]* 29.3 [27.4 - 29.6]
4 l/min 39.0 [38.0 - 40.0] 34.0 [33.0 - 34.6]† 36.6 [34.5 - 38.0]*
8 l/min 70.4 [67.5 - 71.9] 53.1 [51.2 - 54.0]† 49.5 [47.1 - 51.6]†
† p < 0.0001 ; * p < 0.05 compared to control group (no leakage).
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there were fewer hospital admissions. SPO2 at home was
not reported [5,6].
Although some studies show no improvement in mor-
tality [5,6,11], the physiological basis for NIV is clear; it
relaxes the inspiratory muscles. External PEEP should
counteract intrinsic PEEP [12], and VA/Q ratios may be
improved [13]. However, leakage caused by movement
of the mask is common. Opening the mouth, and poorFigure 2 Show the variations of FiO2 with leaks.fit to the face associated with weight loss, leads to
leakage, especially at night [14]. Fortunately, many
home ventilators now have well-developed software to
detect and compensate for leaks from room air, and
can compensate for leakage of about 30 l.min-1[15].
Nevertheless, leaks can decrease the delivered FiO2
because the O2 supply is constant, as demonstrated
here. NIV failure to improve surviving in chronic COPD
may be due to this.
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value of which is increased by oxygen supplementation
with home ventilators. Thys and Schwartz showed the
influence of site oxygen delivery on FiO2 [16,17]. Although
in several home ventilators using a liquid O2 source or an
O2 extractor, FiO2 can be monitored but it is not possible
to set. Unfortunately regulation of FiO2 with home ventila-
tors is not yet available. Our study is the first to focus
on the affect of leakage on FiO2 during NIV with home
ventilators, although such effects have been previously
shown with ICU ventilators [18]. In several conditions
FiO2 can vary by up to 30%. With the O2 supply of 8 l.
min-1 we found a decrease in FiO2 from 70 to 50% with a
leakage of 10 l.min-1.
NIV offers an excellent treatment for chronic respira-
tory insufficiency, but in the home there is no control of
leaks or measurement of SPO2. In a recent meta-analyse
Chen et al. point out that with an inspiratory positive
airway pressure (IPAP) greater or equal than 14 cmH2O
the PaO2 decreased [19]; increasing of leaks with high
airway pressure should explain that. With increasing
leakage, FiO2 decreases, and hypoxemia ensues leading
to an increase of minute respiratory intake which in
turn results in aspirating room air; if the O2 supply is
constant then FiO2 decreases again leading a vicious circle
of hypoxemia. This may explain the poor results of
treating respiratory failure with NIV in the home.
The O2 supply can be triggered by the patient’s SpO2 or
the ventilator FiO2. The former is more relevant clinically;
the latter is more easily measured. The cost of measuring
FiO2 is about 1000 Euros; SpO2 is less expensive but the
measurement is subject to artefacts.
The design (bench test) limits the impact of the findings.
On the over hand we underestimated the leaks, which
could reach 30 liters per minute; the FiO2 decrease may
be greater in clinical conditions.
We purpose to adjunct and O2 turbine witch should
adjust O2 flow supply to a SpO2 objective.
New home NIV chronic use in COPD study’s should
be conducted with this O2 flow control.
We propose to add a dedicated O2 turbine allowing
automated O2 flow adjustment in order to achieve a
predefined SpO2.
Thereafter, studies will be mandatory to evaluate effects
of this automated O2 flow supply on COPD prognosis.
Conclusion
This lung model study demonstrates that during application
of NIV on home ventilators, leakage can dramatically
decrease FiO2 making it less effective. As consequence,
it is essential to know the FiO2 dispensed during NIV at
home. Further research should explore the role of the
O2 flow control during application of NIV in chronic
hypercapnic COPD patients.We hope that industry can address the problems we
have highlighted in this study.
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